Graham Capital Management, L.P.

Position in EDIT — Editas Medicine, Inc.

CIK 1315421 ROWAYTON, CT

Position in EDIT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$134,369

-$152,434 QoQ

Shares Held

41,472

-70.4% QoQ

Ownership

0.027%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#89

of 216 holders

Holding Since

Dec 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Graham Capital Management, L.P. holds $44,243,780 across 71 Biotechnology names. EDIT ranks #47 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TVTX	Travere Therapeutics, Inc.	446,696	$25,376,799
2	INCY	Incyte Corp	15,632	$1,772,043
3	IONS	Ionis Pharmaceuticals Inc	16,717	$1,325,490
4	VKTX	Viking Therapeutics, Inc.	22,114	$862,667
5	ALNY	Alnylam Pharmaceuticals, Inc.	2,256	$679,123
6	ARVN	Arvinas, Inc.	81,364	$676,134
7	PCVX	Vaxcyte, Inc.	11,107	$645,649
8	MRVI	Maravai Lifesciences Holdings, Inc.	92,277	$575,808

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$134,369	41,472	-70.4%	Shares	Sole	2026-08-14
2025-12-31	$286,803	139,904	+108.6%	Shares	Sole	2026-02-17
2025-09-30	$232,781	67,084	+65.1%	Shares	Sole	2025-11-14
2025-06-30	$89,392	40,633	-34.6%	Shares	Sole	2025-08-14
2024-03-31	$460,826	62,106	+303.8%	Shares	Sole	2024-05-15
2023-12-31	$155,809	15,381	-52.5%	Shares	Sole	2024-02-14
2023-09-30	$252,376	32,356	-2.2%	Shares	Sole	2023-11-22
2023-06-30	$272,314	33,088	-79.1%	Shares	Sole	2023-08-14
2022-09-30	$1,936,196	158,186	+9.8%	Shares	Sole	2022-11-14
2022-06-30	$1,704,466	144,080	+1059.2%	Shares	Sole	2022-08-15
2021-12-31	$329,989	12,429	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.